Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

Objective measurement of tissue tension in myofascial trigger point areas before and during the administration of anesthesia with complete blocking of neuromuscular transmission.

Buchmann J, Neustadt B, Buchmann-Barthel K, Rudolph S, Klauer T, Reis O, Smolenski U, Buchmann H, Wagner KF, Haessler F.

Clin J Pain. 2014 Mar;30(3):191-8. doi: 10.1097/AJP.0b013e3182971866.

PMID:
23689350
2.

Desmopressin-induced Moschcowitz-like syndrome after treatment of uterine atonic bleeding in a 28-year-old pregnant woman: case report and overview of the literature.

Dieterich M, Mann E, Wagner KF, Kramer-Steiner B, Reimer T, Gerber B, Stubert J.

Blood Coagul Fibrinolysis. 2011 Dec;22(8):749-51. doi: 10.1097/MBC.0b013e32834aa7f1.

PMID:
21921792
3.

Erythropoietin as additive of HTK preservation solution in cold ischemia/reperfusion injury of steatotic livers.

Eipel C, Hübschmann U, Abshagen K, Wagner KF, Menger MD, Vollmar B.

J Surg Res. 2012 Mar;173(1):171-9. doi: 10.1016/j.jss.2010.09.008. Epub 2010 Nov 10.

PMID:
21074785
4.

Transmyocardial laser revascularization combined with intramyocardial endothelial progenitor cell transplantation in patients with intractable ischemic heart disease ineligible for conventional revascularization: preliminary results in a highly selected small patient cohort.

Babin-Ebell J, Sievers HH, Charitos EI, Klein HM, Jung F, Hellberg AK, Depping R, Sier HA, Marxsen J, Stoelting S, Kraatz EG, Wagner KF.

Thorac Cardiovasc Surg. 2010 Feb;58(1):11-6. doi: 10.1055/s-0029-1186199. Epub 2010 Jan 13.

PMID:
20072970
5.

CD133+ cells from bone marrow have a greater stem cell potential than CD133+ cells from stem cell apheresates.

Kuta P, Wagner KF, Peters SO, Wagner T, Sier H, Stoelting S.

J Stem Cells Regen Med. 2010 Oct 23;6(2):105-6. eCollection 2010. No abstract available.

PMID:
24693120
6.

Male germ cell expression of the PAS domain kinase PASKIN and its novel target eukaryotic translation elongation factor eEF1A1.

Eckhardt K, Troger J, Reissmann J, Katschinski DM, Wagner KF, Stengel P, Paasch U, Hunziker P, Borter E, Barth S, Schlafli P, Spielmann P, Stiehl DP, Camenisch G, Wenger RH.

Cell Physiol Biochem. 2007;20(1-4):227-40.

7.

Non-hypoxic induction of HIF-3alpha by 2-deoxy-D-glucose and insulin.

Heidbreder M, Qadri F, Jöhren O, Dendorfer A, Depping R, Fröhlich F, Wagner KF, Dominiak P.

Biochem Biophys Res Commun. 2007 Jan 12;352(2):437-43. Epub 2006 Nov 16.

PMID:
17125738
8.

Expression of the erythropoietin receptor in human heart.

Depping R, Kawakami K, Ocker H, Wagner JM, Heringlake M, Noetzold A, Sievers HH, Wagner KF.

J Thorac Cardiovasc Surg. 2005 Sep;130(3):877-8. No abstract available.

9.

Cardiac remodeling in erythropoietin-transgenic mice.

Briest W, Homagk L, Baba HA, Deten A, Rassler B, Tannapfel A, Wagner KF, Wenger RH, Zimmer HG.

Cell Physiol Biochem. 2004;14(4-6):277-84.

10.

Hypoxia-induced mitogenic factor has antiapoptotic action and is upregulated in the developing lung: coexpression with hypoxia-inducible factor-2alpha.

Wagner KF, Hellberg AK, Balenger S, Depping R, Dodd-O J, Johns RA, Li D.

Am J Respir Cell Mol Biol. 2004 Sep;31(3):276-82. Epub 2004 Apr 29.

PMID:
15117738
11.

A dominant-negative isoform of hypoxia-inducible factor-1 alpha specifically expressed in human testis.

Depping R, Hägele S, Wagner KF, Wiesner RJ, Camenisch G, Wenger RH, Katschinski DM.

Biol Reprod. 2004 Jul;71(1):331-9. Epub 2004 Mar 17.

12.

Norepinephrine-induced acute heart failure in transgenic mice overexpressing erythropoietin.

Deten A, Shibata J, Scholz D, Briest W, Wagner KF, Wenger RH, Zimmer HG.

Cardiovasc Res. 2004 Jan 1;61(1):105-14.

13.

Altered pulmonary vascular reactivity in mice with excessive erythrocytosis.

Hasegawa J, Wagner KF, Karp D, Li D, Shibata J, Heringlake M, Bahlmann L, Depping R, Fandrey J, Schmucker P, Uhlig S.

Am J Respir Crit Care Med. 2004 Apr 1;169(7):829-35. Epub 2003 Dec 30.

PMID:
14701712
14.

Targeted disruption of the mouse PAS domain serine/threonine kinase PASKIN.

Katschinski DM, Marti HH, Wagner KF, Shibata J, Eckhardt K, Martin F, Depping R, Paasch U, Gassmann M, Ledermann B, Desbaillets I, Wenger RH.

Mol Cell Biol. 2003 Oct;23(19):6780-9.

15.

Hemostasis and coagulation at a hematocrit level of 0.85: functional consequences of erythrocytosis.

Shibata J, Hasegawa J, Siemens HJ, Wolber E, Dibbelt L, Li D, Katschinski DM, Fandrey J, Jelkmann W, Gassmann M, Wenger RH, Wagner KF.

Blood. 2003 Jun 1;101(11):4416-22. Epub 2003 Feb 6.

16.

Rescue of a patient out of a grain container: the quicksand effect of grain.

Bahlmann L, Klaus S, Heringlake M, Baumeier W, Schmucker P, Wagner KF.

Resuscitation. 2002 Apr;53(1):101-4.

PMID:
11947986
17.

Isoform-specific expression of hypoxia-inducible factor-1alpha during the late stages of mouse spermiogenesis.

Marti HH, Katschinski DM, Wagner KF, Schäffer L, Stier B, Wenger RH.

Mol Endocrinol. 2002 Feb;16(2):234-43.

18.

Physiologically low oxygen concentrations in fetal skin regulate hypoxia-inducible factor 1 and transforming growth factor-beta3.

Scheid A, Wenger RH, Schäffer L, Camenisch I, Distler O, Ferenc A, Cristina H, Ryan HE, Johnson RS, Wagner KF, Stauffer UG, Bauer C, Gassmann M, Meuli M.

FASEB J. 2002 Mar;16(3):411-3. Epub 2002 Jan 14.

PMID:
11790723
19.

Heat induction of the unphosphorylated form of hypoxia-inducible factor-1alpha is dependent on heat shock protein-90 activity.

Katschinski DM, Le L, Heinrich D, Wagner KF, Hofer T, Schindler SG, Wenger RH.

J Biol Chem. 2002 Mar 15;277(11):9262-7. Epub 2002 Jan 4.

20.

Chronic inborn erythrocytosis leads to cardiac dysfunction and premature death in mice overexpressing erythropoietin.

Wagner KF, Katschinski DM, Hasegawa J, Schumacher D, Meller B, Gembruch U, Schramm U, Jelkmann W, Gassmann M, Fandrey J.

Blood. 2001 Jan 15;97(2):536-42.

21.

Measurement of peripheral tissue thickness by ultrasound during the perioperative period.

Schumacher J, Engelke A, Wagner KF, Eichler W, Markert U, Klotz KF.

Br J Anaesth. 1999 Apr;82(4):641-3.

22.

Is CD30 (Ki-1) immunostaining in cutaneous eruptions useful as a marker of Th1 to Th2 cytokine switching and/or as a marker of advanced HIV-1 disease?

Smith KJ, Barrett TL, Neafie R, Tomaszewski MM, Yeager J, Nelson A, Wagner KF, Skelton HG.

Br J Dermatol. 1998 May;138(5):774-9.

PMID:
9666821
23.
24.
25.

Once weekly azithromycin therapy for prevention of Mycobacterium avium complex infection in patients with AIDS: a randomized, double-blind, placebo-controlled multicenter trial.

Oldfield EC 3rd, Fessel WJ, Dunne MW, Dickinson G, Wallace MR, Byrne W, Chung R, Wagner KF, Paparello SF, Craig DB, Melcher G, Zajdowicz M, Williams RF, Kelly JW, Zelasky M, Heifets LB, Berman JD.

Clin Infect Dis. 1998 Mar;26(3):611-9.

PMID:
9524832
26.

Size and duration of zidovudine benefit in 1003 HIV-infected patients: U.S. Army, Navy, and Air Force natural history data. Military Medical Consortium for Applied Retroviral Research.

Gardner LI, Harrison SH, Hendrix CW, Blatt SP, Wagner KF, Chung RC, Harris RW, Cohn DL, Burke DS, Mayers DL.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Apr 1;17(4):345-53.

PMID:
9525436
27.
28.
29.

Clinical significance of discordant CD4 count and CD4 percentage in HIV-infected individuals.

Le TP, Tribble DR, Zhou SY, Malone L, Chung RC, Rusnak JM, Wagner KF.

AIDS. 1997 Sep;11(11):1395-6. No abstract available.

PMID:
9302451
31.

Impaired induction of the apoptosis-protective protein Bcl-xL in activated PBMC from asymptomatic HIV-infected individuals.

Blair PJ, Boise LH, Perfetto SP, Levine BL, McCrary G, Wagner KF, St Louis DC, Thompson CB, Siegel JN, June CH.

J Clin Immunol. 1997 May;17(3):234-46.

PMID:
9168404
32.

Evolution of human immunodeficiency virus type 1 env sequence variation in patients with diverse rates of disease progression and T-cell function.

McDonald RA, Mayers DL, Chung RC, Wagner KF, Ratto-Kim S, Birx DL, Michael NL.

J Virol. 1997 Mar;71(3):1871-9.

33.

Measurement of CD69 induction in the assessment of immune function in asymptomatic HIV-infected individuals.

Perfetto SP, Hickey TE, Blair PJ, Maino VC, Wagner KF, Zhou S, Mayers DL, St Louis D, June CH, Siegel JN.

Cytometry. 1997 Feb 15;30(1):1-9.

PMID:
9056736
34.

Mucosal immune responses in four distinct compartments of women infected with human immunodeficiency virus type 1: a comparison by site and correlation with clinical information.

Artenstein AW, VanCott TC, Sitz KV, Robb ML, Wagner KF, Veit SC, Rogers AF, Garner RP, Byron JW, Burnett PR, Birx DL.

J Infect Dis. 1997 Feb;175(2):265-71.

PMID:
9203646
37.

Pruritus in HIV-1 disease: therapy with drugs which may modulate the pattern of immune dysregulation.

Smith KJ, Skelton HG, Yeager J, Lee RB, Wagner KF.

Dermatology. 1997;195(4):353-8.

PMID:
9529556
38.
39.

Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulation.

Levine BL, Mosca JD, Riley JL, Carroll RG, Vahey MT, Jagodzinski LL, Wagner KF, Mayers DL, Burke DS, Weislow OS, St Louis DC, June CH.

Science. 1996 Jun 28;272(5270):1939-43.

PMID:
8658167
40.

Intact antigen receptor-mediated calcium signals in patients with early stage HIV-1 infection.

Hickey TE, Blair PJ, Perfetto S, Smoot DS, Wagner KF, St Louis DC, Mayers DL, Siegel JN, June CH.

J Immunol. 1996 May 15;156(10):4012-7.

PMID:
8621943
41.

Phase I trial of interferon alfa-n3 in early-stage human immunodeficiency virus type 1 disease: evidence for drug safety, tolerance, and antiviral activity.

Skillman DR, Malone JL, Decker CF, Wagner KF, Mapou RL, Liao MJ, Testa D, Meltzer MS.

J Infect Dis. 1996 May;173(5):1107-14.

PMID:
8627061
42.

Bacillus piliformis infection (Tyzzer's disease) in a patient infected with HIV-1: confirmation with 16S ribosomal RNA sequence analysis.

Smith KJ, Skelton HG, Hilyard EJ, Hadfield T, Moeller RS, Tuur S, Decker C, Wagner KF, Angritt P.

J Am Acad Dermatol. 1996 Feb;34(2 Pt 2):343-8. Review.

PMID:
8655723
43.

Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.

Mascola JR, Snyder SW, Weislow OS, Belay SM, Belshe RB, Schwartz DH, Clements ML, Dolin R, Graham BS, Gorse GJ, Keefer MC, McElrath MJ, Walker MC, Wagner KF, McNeil JG, McCutchan FE, Burke DS.

J Infect Dis. 1996 Feb;173(2):340-8.

PMID:
8568294
44.

Clinical and histopathologic features of hair loss in patients with HIV-1 infection.

Smith KJ, Skelton HG, DeRusso D, Sperling L, Yeager J, Wagner KF, Angritt P.

J Am Acad Dermatol. 1996 Jan;34(1):63-8.

PMID:
8543696
45.

Decreased CD7 expression in cutaneous infiltrates of HIV-1+ patients. Military Medical Consortium for the Advancement of Retroviral Research (MMCARR).

Smith KJ, Skelton HG, Chu WS, Yeager J, Angritt P, Wagner KF.

Am J Dermatopathol. 1995 Dec;17(6):564-9.

PMID:
8599470
46.

Bovine collagen hemostatic agent used in removal of a basal cell carcinoma of the nose with a good cosmetic result.

Smith KJ, Skelton HG, Turiansky G, Wagner KF.

Dermatol Surg. 1995 Oct;21(10):907-9. No abstract available.

PMID:
7551750
47.

Metronidazole for eosinophilic pustular folliculitis in human immunodeficiency virus type 1-positive patients.

Smith KJ, Skelton HG, Yeager J, Ruiz N, Wagner KF.

Arch Dermatol. 1995 Sep;131(9):1089-91. No abstract available.

PMID:
7661619
49.

Bovine collagen products and gelatin sponges for hemostasis in punch biopsies of HIV-1+ patients.

Smith KJ, Skelton HG, Yeager J, Wagner KF.

Dermatol Surg. 1995 Jun;21(6):563-4. No abstract available.

PMID:
7773606
50.

Increased anticardiolipin antibodies associated with the development of anetoderma in HIV-1 disease. Military Medical Consortium for the Advancement of Retroviral research (MMCARR).

Lindstrom J, Smith KJ, Skelton HG, Redfield R, Alving BM, Wagner KF, Lupton GP.

Int J Dermatol. 1995 Jun;34(6):408-15.

PMID:
7657440

Supplemental Content

Loading ...
Support Center